https://www.businesswire.com/news/home/20260420953740/en/Bicycle-Therapeutics-Provides-Update-on-Nuzefatide-Pevedotin-and-EphA2-Pipeline-at-the-AACR-Annual-Meeting-2026
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual...
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic...